Prokaryotics

About:

Prokaryotics is a biopharmaceutical company focused on the discovery and development of novel antibiotic classes.

Website: http://prokaryotics.com/

Top Investors: National Institutes of Health

Description:

Prokaryotics is a biopharmaceutical company focused on the discovery and development of novel antibiotic classes that target serious multi-drug resistant bacterial infections. Prokaryotics leverages deep knowledge of bacterial physiology, innovative screening strategies, and scientific excellence necessary to discover and develop new classes of antibiotics targeting outer membrane biogenesis - the fundamental armor erected by bacteria to naturally withstand the effects of antibiotics.